Injectable Drug Delivery Market - Safer, Simpler, Smarter Devices | Market Value to Worth Over US$ 32.5 Billion at 8.3% CAGR by 2027

Global Injectable Drug Delivery Market – Market Insights

Injectable drug delivery is referred to as the most effective administration route for delivering drugs to the targeted sites effectively, which improves the compliance of patients towards the drug. Injectable delivery promotes rapid drug absorption from different sites including intravenous, intramuscular and subcutaneous. The injectable delivery enhances the drug’s bioavailability during systemic circulation, offering drug availability at the intended site.

The global injectable drug delivery market size accounted for US$ 15,939.0 Mn in 2017, and is expected to witness a CAGR of 8.3% over the forecast period (2018 – 2026).

Get Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/2768

Global Injectable Drug Delivery Market – Drivers

Rising pervasiveness of chronic diseases such as diabetes, anaphylaxis among others is expected to drive global injectable drug delivery market growth. As per the World Health Organization (WHO), in November 2011, around 60 million Europeans had diabetes, among which nearly 10.3 percent were men and 9.6 percent were women of age 25 years and above. Likewise, as per the 2018 factsheet of World Health Organization (WHO), in 2014, over 8.5% of adults 18 year old and above suffered from diabetes in the world.

Moreover, the players in market are stressing on injectors launch and product development, this is expected to fuel global injectable drug delivery market growth over the forecast period. For instance, Berlin-Chemie, in Germany, introduced BerliPen areo 3, in 2016. BerliPen areo 3 is an insulin pen of 300 units, with which six different insulins can be used for treating diabetes of type 1 and 2. Similarly, Teva Pharmaceuticals, in August 2018, received approval from the U.S. Food and Drug Administration (FDA) for the generic version of Mylan’s EpiPen Jr. and EpiPen. Teva Pharmaceuticals is a manufacturer of generic medicines and the first one to receive the approval from FDA.

Tailored Information as per niche requirement:

LIMITED TIME OFFER - Hurry Up!

Exclusive offer!!! Purchase the report at a discounted rate!!!

Get Discount For Buyers UPTO 30% OFF On Any Research Report 

Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/2768

However, rising product recalls are expected to hamper growth of the global injectable drug delivery market. Bracco Diagnostics Inc., in December 2012, instigated a recall of Class of nine lots of Isovue Pre-Filled Power Injector Syringes, these are used with Stellant CT Injection Systems, owing to visible particles present in syringes noticed during the standard stability studies carried on retained samples, as per the U.S. Food and Drug Administration (FDA)

Rising approval and launch of products North America is expected to aid the market growth

North America owns the highest share in global injectable drug delivery market, due to regional players increasingly focusing on product launches and development and research. For instance,  Bayer, in 2017, received the approval of the U.S. Food and Drug Administration (FDA) BETACONNECT- a connected auto-injector for relapsing-remitting multiple sclerosis and myBETAapp- a companion app. Patients can automatically keep and share records of all their injections with their physician or nurse with the help of this app. Similarly, Genentech, in October 2018, announced the approval from the U.S. Food and Drug Administration (FDA) for single-dose prefilled syringes (PFS), Xolair (omalizumab) as an added formulation for treating both chronic idiopathic urticaria (CIU) and allergic asthma indications.

Furthermore, rising occurrences of chronic diseases including anaphylaxis, cardiac arrest and diabetes in this region is expected to fuel the global injectable drug delivery market growth during the forecast period. For instance,as per the Allergy and Clinical Immunology journal, in 2014, there was 1.6% pervasiveness of anaphylaxis among the U.S. general population, and number of hospitalizations linked to the disease is continuously surging in the U.S.

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/injectable-drug-delivery-market-to-surpass-us-325-billion-by-2026-1457

Moreover, rising company initiatives for ensuring the availability of auto-injectors to anaphylaxis patients is expected to bolster the global injectable drug delivery market growth. For instance, Mylan N.V. offers discount cards to consumers buying epinephrine, and provides concessions up to US$ 300 on EpiPen’s branded version and up to US$ 25 on EpiPen’s approved generic version.

Key Players

Key players functioning in global injectable drug delivery market consists of Becton, Pfizer Inc., Dickinson and Company, Novo Nordisk A/S, Carl-Zeiss-Stiftung, SHL Group, Gerresheimer AG, Terumo Corporation, Injex Pharma GmbH, Vetter Pharma-Fertigung GmbH & Co. KG, and Owen Mumford Limited.

Table of Contents

1. Research Objectives and Assumptions
• Research Objectives
• Assumptions
• Abbreviations
2. Market Purview
• Report Description
• Market Definition and Scope
• Executive Summary
• Market Snippet, By Device Type
• Market Snippet, By Material Type
• Market Snippet, By Usability
• Market Snippet, By Route of Administration
• Market Snippet, By End User
• Market Snippet, By Region
• Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
• Market Dynamics
• Drivers
• Restraints
• Market Opportunities
• Impact Analysis
• Regulatory Scenario
• PEST Analysis
• Partnership and Acquisition Scenario
• Recent Product Launches/Approvals
• Technological Evolution
• Market Trends
4. Global Injectable Drug Delivery Market, By Device Type, 2018 – 2026, (US$ Mn)
• Introduction
• Market Share Analysis, 2018 and 2026 (%)
• Y-o-Y Growth Analysis, 2017 – 2026
• Segment Trends
• Prefilled Syringes
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
• Auto Injectors
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
• Pens
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
• Conventional Syringes
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
• Cartridges
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
• Ampoules
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
• Vials
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
• Others
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
5. Global Injectable Drug Delivery Market, By Material Type, 2018 – 2026, (US$ Mn)
• Introduction
• Market Share Analysis, 2018 and 2026 (%)
• Y-o-Y Growth Analysis, 2017 – 2026
• Segment Trends
• Glass
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
• Plastic
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
6. Global Injectable Drug Delivery Market, By Usability, 2018 – 2026, (US$ Mn)
• Introduction
• Market Share Analysis, 2018 and 2026 (%)
• Y-o-Y Growth Analysis, 2017 – 2026
• Segment Trends
• Disposable
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
• Reusable
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
7. Global Injectable Drug Delivery Market, By Route of Administration, 2018 – 2026, (US$ Mn)
• Introduction
• Market Share Analysis, 2018 and 2026 (%)
• Y-o-Y Growth Analysis, 2017 – 2026
• Segment Trends
• Intravenous
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
• Intramuscular
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
• Subcutaneous
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
8. Global Injectable Drug Delivery Market, By End User, 2018 – 2026, (US$ Mn)
• Introduction
• Market Share Analysis, 2018 and 2026 (%)
• Y-o-Y Growth Analysis, 2017 – 2026
• Segment Trends
• Hospitals
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
• Clinics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
• Ambulatory Surgical Centers
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
• Home Care Settings
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
• Others
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
9. Global Injectable Drug Delivery Market, By Region, 2018 – 2026, (US$ Mn)
• Introduction
• Market Share Analysis, By Region, 2018 and 2026 (%)
• Y-o-Y Growth Analysis, For Regions, 2017–2026
• North America
• Market Size and Forecast, By Device Type, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Material Type, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Usability, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
• U.S.
• Canada
• Latin America
• Market Size and Forecast, By Device Type, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Material Type, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Usability, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• Market Size and Forecast, By Device Type, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Material Type, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Usability, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
• Germany
• U.K.
• France        
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• Market Size and Forecast, By Device Type, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Material Type, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Usability, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of APAC
• Middle East
• Market Size and Forecast, By Device Type, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Material Type, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Usability, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
• GCC
• Israel
• Rest of Middle East
• Africa
• Market Size and Forecast, By Device Type, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Material Type, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Usability, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Route of Administration, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By End User, 2016 – 2026, (US$ Mn)
• Market Size and Forecast, By Country/Region, 2016 – 2026, (US$ Mn)
• South Africa
• Central Africa
• North Africa
10. Competitive Landscape
• Heat Map Analysis
• Company Profiles
• Analyst Views
11. Section
• References
• Research Methodology
• About us and Sales Contact

Other Related News:

U.K. Drug for Abuse Testing Devices Market to Surpass US$ 389.1 Million By 2027

Smart Syringe Market to Surpass US$ 15,542.2 Million By 2027

Drug-Device Combination Products Market to Surpass US$ 214.0 Billion By 2027

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837